New Zealand markets close in 4 hours 5 minutes

Novo Nordisk A/S (NVO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
89.04+1.26 (+1.44%)
At close: 04:00PM EDT
89.00 -0.04 (-0.04%)
After hours: 07:54PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 393.18B
Enterprise value 391.68B
Trailing P/E 41.64
Forward P/E 30.30
PEG ratio (5-yr expected) 5.10
Price/sales (ttm)13.91
Price/book (mrq)30.64
Enterprise value/revenue 1.95
Enterprise value/EBITDA 4.48

Trading information

Stock price history

Beta (5Y monthly) 0.24
52-week change 365.58%
S&P500 52-week change 311.79%
52-week high 3100.88
52-week low 350.44
50-day moving average 390.69
200-day moving average 379.62

Share statistics

Avg vol (3-month) 33.76M
Avg vol (10-day) 34.46M
Shares outstanding 54.47B
Implied shares outstanding 64.59B
Float 825.72B
% held by insiders 10.01%
% held by institutions 18.22%
Shares short (14 Sept 2023) 45.61M
Short ratio (14 Sept 2023) 41.44
Short % of float (14 Sept 2023) 4N/A
Short % of shares outstanding (14 Sept 2023) 40.13%
Shares short (prior month 14 Aug 2023) 44.1M

Dividends & splits

Forward annual dividend rate 41.03
Forward annual dividend yield 41.18%
Trailing annual dividend rate 37.07
Trailing annual dividend yield 38.06%
5-year average dividend yield 41.80
Payout ratio 441.49%
Dividend date 328 Aug 2023
Ex-dividend date 417 Aug 2023
Last split factor 22:1
Last split date 319 Sept 2023

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Jun 2023

Profitability

Profit margin 33.40%
Operating margin (ttm)43.20%

Management effectiveness

Return on assets (ttm)21.76%
Return on equity (ttm)81.54%

Income statement

Revenue (ttm)201.33B
Revenue per share (ttm)5.59
Quarterly revenue growth (yoy)31.60%
Gross profit (ttm)148.51B
EBITDA 92.89B
Net income avi to common (ttm)67.24B
Diluted EPS (ttm)2.11
Quarterly earnings growth (yoy)45.90%

Balance sheet

Total cash (mrq)36.41B
Total cash per share (mrq)1.01
Total debt (mrq)25.7B
Total debt/equity (mrq)28.41%
Current ratio (mrq)0.88
Book value per share (mrq)2.52

Cash flow statement

Operating cash flow (ttm)89.73B
Levered free cash flow (ttm)53.32B